Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Drugs, Investigational

"Drugs, Investigational" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

Drugs which have received FDA approval for human testing but have yet to be approved for commercial marketing. This includes drugs used for treatment while they still are undergoing clinical trials (Treatment IND). The main heading includes drugs under investigation in foreign countries.


This graph shows the total number of publications written about "Drugs, Investigational" by people in Harvard Catalyst Profiles by year, and whether "Drugs, Investigational" was a major or minor topic of these publication.
Bar chart showing 128 publications over 26 distinct years, with a maximum of 10 publications in 2010 and 2013 and 2014
To see the data from this visualization as text, click here.
Related Networks
People
Explore
_
Similar Concepts
_
Top Journals 
_
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.